PROCEPT BioRobotics (Nasdaq: PRCT), today announced the international expansion of the HYDROS Robotic System, the company’s next-generation platform for delivering Aquablation therapy to treat benign ...
Procept BioRobotics today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.
We came across a bullish thesis on PROCEPT BioRobotics Corporation on Notes From The Beauty Contest’s Substack by Crashkolnikov. In this article, we will summarize the bulls’ thesis on PRCT. PROCEPT ...
PROCEPT BioRobotics (NASDAQ:PRCT) used its 2026 Analyst Day to outline what management characterized as a large, underpenetrated opportunity in benign prostatic hyperplasia (BPH), a developing ...
Fintel reports that on March 6, 2026, Baird initiated coverage of PROCEPT BioRobotics (NasdaqGM:PRCT) with a Neutral recommendation. Analyst Price Forecast Suggests 122.20% Upside As of February 25, ...
Jefferies initiated coverage of Procept BioRobotics (PRCT) with a Hold rating and $95 price target The firm’s checks suggest the Hydros system launch could catalyze a replacement cycle among systems ...
Director Antal Rohit Desai of PROCEPT BioRobotics Corp (NASDAQ:PRCT) reported purchasing shares of common stock in multiple transactions between March 5 and March 9, 2026. The total value of these ...
Detailed price information for Procept Biorobotics Corp (PRCT-Q) from The Globe and Mail including charting and trades.
PROCEPT BioRobotics PRCT is gearing up to announce its quarterly earnings on Wednesday, 2025-08-06. Here's a quick overview of what investors should know before the release. Analysts are estimating ...
Company outlines path to leadership in BPH, including near-term focus on procedure growth through patient-centric solutions and increased organizational disciplineStrong revenue outlook, procedure ...
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics develops, manufactures and sells the ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results